Suitability evaluation of toehold switch and EXPAR for cell-free MicroRNA biosensor development
Caroline E Copeland1, Yong-Chan Kwon1,2
1Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, 70803, USA.
Biotechnology Notes (Amsterdam, Netherlands)
|October 17, 2024
Summary
This study developed a portable biosensing platform for microRNA (miRNA) detection using toehold switch technology and exponential amplification reaction (EXPAR). The optimized system offers a cost-effective and accurate method for disease monitoring.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Biosensing
Background:
- MicroRNA (miRNA) detection is crucial for disease monitoring, but current methods lack accuracy and are costly.
- The toehold switch riboregulator shows promise for RNA detection within cell-free systems (CFS).
- Existing miRNA detection techniques face challenges with accuracy, cost, and stability.
Purpose of the Study:
- To develop a robust, cost-effective, and portable sensing platform for miRNA detection.
- To integrate toehold switch technology with exponential amplification reaction (EXPAR) for enhanced sensitivity.
- To optimize the combined system for clinically relevant miRNA detection levels.
Main Methods:
- Utilized toehold switch riboregulators for miRNA recognition within a freeze-dried cell-free system (CFS).
- Incorporated exponential amplification reaction (EXPAR) for signal amplification.
- Systematically assessed various EXPAR DNA templates and toehold switch structures for optimal performance.
Main Results:
- Optimized EXPAR DNA templates and toehold switch designs to improve sensing accuracy and sensitivity.
- Demonstrated the feasibility of detecting synthetic miRNA and EXPAR products with enhanced sensitivity.
- Elucidated the synergistic mechanisms of toehold switch and EXPAR in the developed platform.
Conclusions:
- The combined toehold switch and EXPAR system offers a promising approach for sensitive and accurate miRNA detection.
- This portable biosensing platform has the potential for cost-effective disease monitoring.
- Further investigation into the benefits and drawbacks of the integrated system is warranted.


